IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2013 | $39,000 | – | 19,998 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Callan Capital, LLC | 70,000 | $65,000 | 0.02% |
Wellington Shields Capital Management, LLC | 51,000 | $47,000 | 0.01% |
Ifrah Financial Services, Inc. | 18,500 | $17,000 | 0.01% |
CHELSEA COUNSEL CO | 28,000 | $26,000 | 0.01% |
DRW Securities, LLC | 120,000 | $111,000 | 0.01% |
TUDOR INVESTMENT CORP ET AL | 66,303 | $61,000 | 0.00% |
OPPENHEIMER & CO INC | 107,000 | $99,000 | 0.00% |
First Allied Advisory Services, Inc. | 45,000 | $42,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $65,000 | 0.00% |
GROUP ONE TRADING, L.P. | 160,103 | $148,000 | 0.00% |